Clinical implications of lamivudine resistance by HBV

被引：30

作者：

Schalm, SW

机构：

来源：

LANCET | 1997年 / 349卷 / 9044期

关键词：

D O I：

10.1016/S0140-6736(05)62154-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3 / 4

页数：2

共 7 条

[1] EFFICACY OF LAMIVUDINE ON REPLICATION OF HEPATITIS-B VIRUS IN HIV-INFECTED PATIENTS [J].

BENHAMOU, Y ;

DOHIN, E ;

LUNELFABIANI, F ;

POYNARD, T ;

HURAUX, JM ;

KATLAMA, C ;

OPOLON, P ;

GENTILINI, M .

LANCET, 1995, 345 (8946) :396-397

[2] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[3] Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine [J].

Ling, R ;

Mutimer, D ;

Ahmed, N ;

Boxall, EH ;

Elias, E ;

Dusheiko, GM ;

Harrison, TJ .

HEPATOLOGY, 1996, 24 (03) :711-713

[4] EUROHEP CONSENSUS REPORT AN THE MANAGEMENT OF LIVER-TRANSPLANTATION FOR HEPATITIS-B VIRUS-INFECTION [J].

MULLER, R ;

SAMUEL, D ;

FASSATI, LR ;

BENHAMOU, JP ;

BISMUTH, H ;

ALEXANDER, GJM .

JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1140-1143

[5]

NIEDERAU C, 1995, NEW ENGL J MED, V333, P1657

[6]

SCHALM SW, 1995, J HEPATOL, V22, P52

[7] Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo [J].

Tipples, GA ;

Ma, MM ;

Fischer, KP ;

Bain, VG ;

Kneteman, NM ;

Tyrrell, DLJ .

HEPATOLOGY, 1996, 24 (03) :714-717

← 1 →